Souhaitez-vous accéder aux communiqués récents ?

JACKSONVILLE, Fla., July 30, 2026 (GLOBE NEWSWIRE) -- MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients...

Highlights FDA End-of-Phase 2 (EOP2) meeting minutes confirmed a registrational pathway for ATH434 in Multiple System Atrophy (MSA)FDA agreed that a single pivotal Phase 3 trial plus confirmatory...

Rhode Island, July 29, 2026 (GLOBE NEWSWIRE) -- The nonprofit Association of Migraine Disorders' global Shades For Migraine campaign achieved record participation in 2026 — reaching millions,...

CARMEL, Ind., July 28, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing...

BEDFORD, Mass., July 22, 2026 (GLOBE NEWSWIRE) -- Spryte Medical, a leader in neuro intravascular imaging, today announced the completion of subject enrollment of the INSYTE Trial, a key milestone...

U.S. Commercial launch of Gen 2 Monarch System commencing today, July 21, 2026Gen 2 Monarch device provides an enhanced patient experience while delivering clinically proven therapeutic stimulation of...

Oxford Brain Diagnostics Advances Vision for Measuring Brain Health and Neurodegenerative Disease with Five New Studies at AAIC 2026

CHARLOTTE, N.C., June 23, 2026 (GLOBE NEWSWIRE) -- Advanced Rehabilitation, LLC today announced the expansion of its educational platform featuring the integrated Kinetic Neuro-Ortho Training...

Halberd Corporation Ships Latest NeuroSense AI Version, Advancing Voice-Based Behavioral Monitoring

MERGE announces its selection as the Agency of Record (AOR) for Supernus Pharmaceuticals, Inc.